• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,754.77 -1,260.51
( -1.66%)
Global Indices
Nasdaq
49,723.13 92.96
(0.19%)
Dow Jones
7,432.82 12.89
(0.17%)
Hang Seng
62,722.92 305.04
(0.49%)
Nikkei 225
10,269.73 36.66
(0.36%)
Forex
USD-INR
94.41 0.04
(0.04%)
EUR-INR
111.23 0.30
(0.27%)
GBP-INR
128.63 0.31
(0.24%)
JPY-INR
0.60 0.00
(-0.10%)

EQUITY - MARKET SCREENER

KCD Industries India Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540696
INE185U01035
16.095701
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
12.64
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Torrent Pharma gets zero-observation USFDA nod for oncology facility
Apr 13,2026
The inspection was conducted between 6 April and 10 April 2026.

A zero-observation outcome indicates that no Form 483 was issued by the regulator, reflecting compliance with current good manufacturing practices (cGMP) at the facility.

The development is positive for the company’s oncology portfolio and supports its regulatory standing in the US market.

Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.

The company’s consolidated net profit jumped 27.6% to Rs 642 crore on 17.7% rise in revenue from operations to Rs 3,251 crore in Q3 FY26 over Q3 FY25

Shares of Torrent Pharmaceuticals rose 0.60% to Rs 4,180 on the BSE.